AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 31 min read$CTS

O'SULLIVAN KIERAN M sold $8.5M of CTS

O'SULLIVAN KIERAN M (President & CEO) sold 130,000 shares of CTS CORP (CTS) at an average of $65.27 ($63.31–$66.67, $8.48M total) across 3 trades over 2026-06-01 to 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · O'SULLIVAN KIERAN M
Published Jun 3, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CTS
Bearish
medium confidence
Mentioned
$CTS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSBearishLow
01

Why it matters

The CEO's $8.5M sale reduces his ownership stake, which could be interpreted by the market as a lack of confidence, potentially prompting short‑term price weakness.

02

Market read

Primary insider sale news; relevant for traders monitoring CTS stock for short‑term moves.

03

What to watch

Potential upcoming corporate actions or financing needs that prompted the pre‑arranged sale.

Relevance 5/10Novelty 5/10Timing: today

Background

SEC Form 4 filings provide the first public disclosure of insider transactions, offering timely insight into insider sentiment.

Company-level read

Ticker impact

$CTSBearishMedium confidence
Context

President & CEO Kieran O'Sullivan sold $8.5M of CTS shares via a 10b5‑1 plan, reducing his stake to 307,693 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A $8.5M open‑market sale by the CEO is material for a mid‑cap stock and can prompt sell‑offs, especially when executed over three days.

Market effects

Sector

Minimal; the sale is company‑specific and does not affect the broader sector.

Regional

None; the filing is U.S.‑focused.

Global

Low; only relevant to CTS investors.

Counterpoint

What could challenge this read

The sale may be purely procedural under the 10b5‑1 plan and not indicative of negative outlook.

Key entities

  • company
    CTS Corp

    Mid‑cap industrial services firm listed on NYSE under ticker CTS.

  • person
    Kieran O'Sullivan

    President & CEO of CTS Corp, insider reporting the sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CTS insider trading history →

Related articles

JUL 30
$CTSMedAI 8/10

CTS Corporation Q2 2026 Earnings Call Summary

CTS Corporation reported Q2 2026 gross margin of 41.5% and said diversified end markets now make up 59% of revenue. Medical sales grew 45% YoY, industrial rose 16%, while transportation fell 2%. Full-year 2026 sales guidance was raised to $565-$585 million. Management expects aerospace strength in H2 and cautions on tariffs and precious metal inflation.

yahoo.com6 min
JUL 28
$CTSMedAI 8/10

Why CTS (CTS) Stock Is Up Today

CTS Corporation (NYSE: CTS) shares rose about 5.8% after the company reported Q2 results that beat expectations and raised full-year guidance. CTS said sales were $144.8 million (+7% YoY) and adjusted EPS was $0.74. It now expects 2026 revenue around $575 million (midpoint) and adjusted EPS of $2.63 (midpoint).

financialcontent.com4 min
JUL 28
$CTSHigh

CTS Announces Second Quarter 2026 Results

CTS CORP (CTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cts-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 July 28, 2026 FOR IMMEDIATE RELEASE CTS Announces Second Quarter 2026 Results Strong diversification momentum drives record margins and profitability; 2026 outlook raised Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading gl

SEC EDGAR 8-K3 min
JUL 24
$CTSMed

ASX Runners of the Week: Ceretas, Pacgold & Hamelin Gold

The article links Middle East tensions to a jump in oil prices, with Brent up about 15% above US$100. It also cites Australia’s June employment gain of 76,300 and unemployment at 4.4%. ASX “runners” include Ceretas Ltd (CTS), up 142% after an $8m IPO for portable ultrasound in Alzheimer’s trials, and Pacgold Ltd (PGO), up 82% after high-grade copper-gold results at White Dam.

theage.com.au6 min